Definium Therapeutics, Inc.

8-K Entered a material agreement; Other events Jun 24, 2026 8-K Regulation FD disclosure; Other events Jun 22, 2026 8-K Director or officer change; Shareholder vote results Jun 12, 2026 8-K Other events May 19, 2026 8-K Other events May 12, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Other events Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change Jan 29, 2026 8-K Results of operations (earnings release); Amended charter or bylaws; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Other events Nov 6, 2025 8-K Entered a material agreement; Other events Oct 31, 2025 8-K Results of operations (earnings release); Other events Oct 29, 2025 8-K Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release); Other events Jul 31, 2025 8-K Director or officer change; Shareholder vote results Jun 16, 2025 8-K Director or officer change; Regulation FD disclosure May 27, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 21, 2025 8-K Other events Apr 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Other events Jan 30, 2025 8-K Director or officer change; Other events Jan 13, 2025 8-K Other events Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 17, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Entered a material agreement; Results of operations (earnings release); Other events Aug 12, 2024 8-K Entered a material agreement; Other events Jun 28, 2024 8-K Other events Jun 20, 2024 8-K Shareholder vote results Jun 11, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024